(Q24245372)

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Antibiotic therapy in infections of the respiratory tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Factors associated with respiratory insufficiency in bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Chloramphenicol treatment of bronchiectasis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Erythromycin therapy for otitis media with effusion in sinobronchial syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Clinical profiles of Chinese patients with diffuse panbronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

Antibiotic prophylaxis in chronic respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Long-term treatment of bronchlectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycinpenicillin mixture

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Cephaloridine compared with penicillin and streptomycin in chronic purulent bronchitis. Controlled trials of increasing dosage of cephaloridine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Chronic bronchitis; an attempt to control chronic infection with Haemophilus influenzae by aerosol therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Long-term oxytetracycline (terramycin) therapy in advanced chronic respiratory infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Nebulizer therapy with antibiotics in chronic suppurative lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Penetration of antibiotics into the respiratory tract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Cefuroxime and ampicillin compared in a double-blind study in the treatment of lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

A pilot study of low-dose erythromycin in bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021

Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB2

7 January 2021